Federal
Stop COVID–19 Test Surprise Medical Bills Act of 2021
Source: Congress.gov ·
934 words in original text
Plain English summary not yet available
The full original text is available below. Check back soon as we process this bill.
I
117TH CONGRESS
1ST SESSION
H. R. 533
To prevent surprise medical bills with respect to COVID–19 testing.
IN THE HOUSE OF REPRESENTATIVES
JANUARY 28, 2021
Mrs. FLETCHER (for herself, Mrs. AXNE, Ms. ESCOBAR, Ms. GARCIA of
Texas, Mr. GRIJALVA, Mr. HASTINGS, Mrs. HAYES, Ms. NORTON, Ms.
JACKSON LEE, Mr. JOHNSON of Georgia, Mr. JONES, Mr. LAWSON of
Florida, Mr. LEVIN of California, Ms. PORTER, Ms. SCHRIER, Mr.
TAKANO, and Ms. VELA´ZQUEZ) introduced the following bill; which was
referred to the Committee on Energy and Commerce, and in addition to
the Committees on Ways and Means, and Education and Labor, for a
period to be subsequently determined by the Speaker, in each case for
consideration of such provisions as fall within the jurisdiction of the com-
mittee concerned
A BILL
To prevent surprise medical bills with respect to COVID–
19 testing.
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled,
2
SECTION 1. SHORT TITLE.
3
This Act may be cited as the ‘‘Stop COVID–19 Test
4
Surprise Medical Bills Act of 2021’’.
5
VerDate Sep 11 2014
23:36 Feb 15, 2021
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H533.IH
H533
kjohnson on DSK79L0C42PROD with BILLS
2
•HR 533 IH
SEC. 2. MEDICAL MANAGEMENT.
1
Section 6001 of the Families First Coronavirus Re-
2
sponse Act (Public Law 116–127) is amended by adding
3
at the end the following:
4
‘‘(e) MEDICAL MANAGEMENT.—For purposes of this
5
section, the term ‘medical management’ includes deter-
6
minations about why an individual sought testing, the na-
7
ture of the clinical assessment that was associated with
8
the testing, whether the individual was showing symptoms,
9
what provider ordered the testing, the frequency of testing
10
obtained by the individual, and other reviews of the en-
11
counters or events that proceeded or followed a service de-
12
scribed in subsection (a). Such term does not include rea-
13
sonable efforts by a group health plan or health insurance
14
issuer to encourage individuals to obtain tests from lower
15
priced providers (provided that such reasonable efforts do
16
not delay or otherwise impede access to testing).’’.
17
SEC. 3. IMPROVEMENTS TO TRANSPARENCY POLICY.
18
(a) IN GENERAL.—Section 3202 of the CARES Act
19
(Public Law 116–136) is amended by adding at the end
20
the following:
21
‘‘(c) IMPROVEMENTS TO TRANSPARENCY POLICY.—
22
Not later than 30 days after the date of enactment of this
23
subsection, the Secretary of Health and Human Services
24
shall survey a sample of providers of the items and serv-
25
ices described in section 6001(a) of division F of the Fam-
26
VerDate Sep 11 2014
23:36 Feb 15, 2021
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6201
E:\BILLS\H533.IH
H533
kjohnson on DSK79L0C42PROD with BILLS
3
•HR 533 IH
ilies First Coronavirus Response Act (Public Law 116–
1
127) regarding the cash prices for such items and services
2
as listed by the providers on a public internet website. The
3
Secretary shall survey no fewer than 200 providers rep-
4
resenting a diversity of sizes, geographic locations, test
5
types, and care settings (such as hospitals, laboratories,
6
and free-standing emergency rooms).
7
‘‘(d) PUBLIC REPORT.—Not later than 45 days after
8
the date of enactment of this subsection, the Secretary of
9
Health and Human Services shall publish a report on cash
10
prices for items and services published under subsection
11
(b)(1), which shall include—
12
‘‘(1) the compliance rate of providers with the
13
cash price publication requirement under subsection
14
(b)(1);
15
‘‘(2) the average cash price for each item and
16
service described in section 6001(a) of division F of
17
the Families First Coronavirus Response Act (Public
18
Law 116–127) and published under subsection
19
(b)(1);
20
‘‘(3) with respect to each such item and service,
21
a comparison of such average cash price to the reim-
22
bursement rate under the Medicare program under
23
title XVIII of the Social Security Act (42 U.S.C.
24
1395 et seq.); and
25
VerDate Sep 11 2014
23:36 Feb 15, 2021
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6201
E:\BILLS\H533.IH
H533
kjohnson on DSK79L0C42PROD with BILLS
4
•HR 533 IH
‘‘(4) any outlier cash prices published under
1
subsection (b)(1) (including the names of the pro-
2
viders charging such prices) that substantially ex-
3
ceed the average cash price.’’.
4
SEC. 4. GUIDANCE ON BILLING FOR PROVIDER VISITS AS-
5
SOCIATED WITH COVID–19 TESTING.
6
The Secretary of Health and Human Services, the
7
Secretary of Labor, and the Secretary of the Treasury,
8
shall jointly issue guidance, not later than 30 days after
9
the date of enactment of this Act for purposes of clari-
10
fying—
11
(1) the process for submitting claims for items
12
and services described in section 6001(a) of the
13
Families First Coronavirus Response Act (Public
14
Law 116–127) to ensure that individuals enrolled in
15
individual or group health insurance coverage or
16
group health plans to whom such items and services
17
are furnished are not subject to cost sharing or prior
18
authorization or other medical management require-
19
ments; and
20
(2) that providers should not collect cost-shar-
21
ing amounts from individuals seeking items and
22
services described in section 6001(a) of such Act.
23
Æ
VerDate Sep 11 2014
23:36 Feb 15, 2021
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\H533.IH
H533
kjohnson on DSK79L0C42PROD with BILLS
Important: This plain English summary was generated by AI and is provided for informational purposes only.
It is not legal advice. Always consult the official bill text on Congress.gov
or a qualified attorney for legal matters.